News & Events
Work With Us Contact Us
×

Clinical Research

PREVENTION is dedicated to the prevention of HIV and other health priorities. We hope to do this through research, education, training and public health advocacy. We not only conduct studies locally, but we also participate in many international research studies.

There are many opportunities awaiting for anyone who wants to make a difference. Studies provide incentives to volunteers for their time and support. If you are interested, please visit the studies below.

HPTN083 Study

HPTN083 Study

Tue 27 Feb 2018

HPTN083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for pre-exposure prophylaxis (PrEP) in HIV-uninfected men and transgender women who have sex with men (MSM and TGW).
Read More

GINI Study

GINI Study

Tue 27 Feb 2018

Gardasil Immunogenicity with Needle-free Injection (GINI) was a study to evaluate the safety and effectiveness of two HPV vaccine delivery regimens; by needle and syringe and needle free jet injection.
Read More

EN-V Study

EN-V Study

Tue 27 Feb 2018

Exploration of the Neo-vagina study (EN-V) is the study to explore neovaginal and rectal HIV transmission risks and assess the feasibility of collecting biological specimens from post-operative transgender women for microbiological, immunological and
Read More

ATS Study

ATS Study

Tue 27 Feb 2018

ATS is a study being done to evaluate the pattern of amphetamine-type use (ATS) by HIV status and the associated demographic and behavioral risk characteristics. The effect of ATS use on HIV and STI incidence among HIV-negative and antiretroviral adh
Read More

ANSAP Study

ANSAP Study

Tue 27 Feb 2018

ANSAP is a study to determine the prevalence and incidence of anal HPV infection and high-grade anal intraepithelial neoplasia (HGAIN), and evaluate their risk factors, among HIV-positive and HIV-negative men who have sex with men (MSM) in Indonesia,
Read More

AIN in AHI Study

AIN in AHI Study

Tue 27 Feb 2018

AIN in AHI is a study to determine the prevalence and incidence of anal high-grade squamous intraepithelial lesion and associated risk factors among MSM who initiate antiretroviral therapy (ART) during acute HIV infection (AHI).
Read More

News & Events